Literature DB >> 35420935

Epithelial monitoring through ligand-receptor segregation ensures malignant cell elimination.

Geert de Vreede1, Stephan U Gerlach1, David Bilder1.   

Abstract

Animals have evolved mechanisms, such as cell competition, to remove dangerous or nonfunctional cells from a tissue. Tumor necrosis factor signaling can eliminate clonal malignancies from Drosophila imaginal epithelia, but why this pathway is activated in tumor cells but not normal tissue is unknown. We show that the ligand that drives elimination is present in basolateral circulation but remains latent because it is spatially segregated from its apically localized receptor. Polarity defects associated with malignant transformation cause receptor mislocalization, allowing ligand binding and subsequent apoptotic signaling. This process occurs irrespective of the neighboring cells' genotype and is thus distinct from cell competition. Related phenomena at epithelial wound sites are required for efficient repair. This mechanism of polarized compartmentalization of ligand and receptor can generally monitor epithelial integrity to promote tissue homeostasis.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35420935      PMCID: PMC9197687          DOI: 10.1126/science.abl4213

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   63.714


  34 in total

Review 1.  Epithelial cell polarity and cell junctions in Drosophila.

Authors:  U Tepass; G Tanentzapf; R Ward; R Fehon
Journal:  Annu Rev Genet       Date:  2001       Impact factor: 16.830

2.  Hemese, a hemocyte-specific transmembrane protein, affects the cellular immune response in Drosophila.

Authors:  Eva Kurucz; Carl-Johan Zettervall; Rita Sinka; Peter Vilmos; Andor Pivarcsi; Sophia Ekengren; Zoltán Hegedüs; Istvan Ando; Dan Hultmark
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-21       Impact factor: 11.205

3.  The Drosophila TNF receptor Grindelwald couples loss of cell polarity and neoplastic growth.

Authors:  Ditte S Andersen; Julien Colombani; Valentina Palmerini; Krittalak Chakrabandhu; Emilie Boone; Michael Röthlisberger; Janine Toggweiler; Konrad Basler; Marina Mapelli; Anne-Odile Hueber; Pierre Léopold
Journal:  Nature       Date:  2015-04-15       Impact factor: 49.962

Review 4.  The Scribble Cell Polarity Module in the Regulation of Cell Signaling in Tissue Development and Tumorigenesis.

Authors:  Rebecca Stephens; Krystle Lim; Marta Portela; Marc Kvansakul; Patrick O Humbert; Helena E Richardson
Journal:  J Mol Biol       Date:  2018-02-08       Impact factor: 5.469

5.  Tumor suppression by cell competition through regulation of the Hippo pathway.

Authors:  Chiao-Lin Chen; Molly C Schroeder; Madhuri Kango-Singh; Chunyao Tao; Georg Halder
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-21       Impact factor: 11.205

Review 6.  Sterile inflammation: sensing and reacting to damage.

Authors:  Grace Y Chen; Gabriel Nuñez
Journal:  Nat Rev Immunol       Date:  2010-11-19       Impact factor: 53.106

7.  Cell competition may function either as tumour-suppressing or as tumour-stimulating factor in Drosophila.

Authors:  L Ballesteros-Arias; V Saavedra; G Morata
Journal:  Oncogene       Date:  2013-10-07       Impact factor: 9.867

8.  The Scribble module regulates retromer-dependent endocytic trafficking during epithelial polarization.

Authors:  Geert de Vreede; Joshua D Schoenfeld; Sarah L Windler; Holly Morrison; Han Lu; David Bilder
Journal:  Development       Date:  2014-07       Impact factor: 6.868

9.  A versatile ΦC31 based reporter system for measuring AP-1 and Nrf2 signaling in Drosophila and in tissue culture.

Authors:  Nirmalya Chatterjee; Dirk Bohmann
Journal:  PLoS One       Date:  2012-04-11       Impact factor: 3.240

10.  Widely Used Mutants of eiger, Encoding the Drosophila Tumor Necrosis Factor, Carry Additional Mutations in the NimrodC1 Phagocytosis Receptor.

Authors:  Albana Kodra; Claire de la Cova; Abigail R Gerhold; Laura A Johnston
Journal:  G3 (Bethesda)       Date:  2020-12-03       Impact factor: 3.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.